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Objectives: Since 1990, transcatheter pulmonary valvotomy has become an
alternative to surgical valvotomy in the management of neonates and
infants with pulmonary atresia and intact ventricular septum. We sought to
determine whether right ventricular growth after transcatheter pulmonary
valvotomy is commensurate with body growth. Methods: Laser or radiofre-
quency-assisted balloon valvotomy was attempted in 12 neonates and
infants with pulmonary atresia and intact ventricular septum. Tricuspid
and mitral valve dimensions were measured retrospectively on the cross-
sectional echocardiograms performed before the procedure and during
follow-up. Z-values were used to standardize tricuspid valve dimensions
with body size. Results: The atretic pulmonary valve was successfully
perforated and dilated in nine of 12 patients. Five of these nine patients
required additional transcatheter or surgical procedures to augment the
pulmonary blood flow. Of six survivors, five are regularly followed up with
a median follow-up of 60 months (range 37 to 68 months). All five have
two-ventricle circulation, two of the five patients requiring surgical enlarge-
ment of the right ventricular outflow tract with or without closure of the
atrial septal defect. Echocardiographic tricuspid valve dimensions and
Z-values before transcatheter valvotomy tended to be smaller in the patients
who died than in the survivors. In the survivors, the absolute tricuspid valve
dimensions increased after valvotomy but the Z-values tended to decrease or
stayed constant. Conclusions: Transcatheter valvotomy is a good alternative to
surgical valvotomy in patients with pulmonary atresia and intact ventricular
septum. Two-ventricle circulation can be achieved despite subnormal right
ventricular growth. (J Thorac Cardiovasc Surg 1998;115:1055-62)
Despite important improvements over the past 30years in the treatment strategies for neonates
with pulmonary atresia and intact ventricular sep-
tum, mortality and morbidity remain significant.1-5
Abnormalities of the coronary artery circulation
together with right ventricular hypoplasia are con-
sidered adverse prognostic factors and may make
biventricular repair difficult if not impossible.1, 5-10
The early establishment of right ventricle–pulmo-
nary artery continuity and antegrade flow, either
alone or combined with a systemic–pulmonary ar-
tery shunt, may promote the growth of the right
ventricle, with the future aim that a normal or near
normal right ventricle would support a two-ventricle
circulation.6, 11-17 Since 1990, transcatheter pulmo-
nary valvotomy, using laser or radiofrequency
heated guide wires followed by balloon dilation, has
been introduced in our unit as an alternative to
surgical valvotomy for pulmonary valve atresia and
intact ventricular septum.18, 19 In this report, we
describe the growth of the right ventricle as assessed
by echocardiography after successful pulmonary val-
votomy.
Methods
Patients. Between April 1990 and April 1995, 15 con-
secutive neonates and infants were admitted to our unit
with pulmonary valve atresia and intact ventricular sep-
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tum. Of these, 12 patients had cardiac catheterization to
attempt transcatheter pulmonary valvotomy as a primary
intervention, after fully informed consent had been ob-
tained. The criteria for attempting catheter valvotomy
included valvular atresia, a coronary circulation not de-
pendent on the right ventricle, and confluent pulmonary
arteries. In three patients, transcatheter intervention was
not performed because the right ventricle was considered
too small in one, the parents opted for a systemic–
pulmonary artery shunt in one, and the coronary artery
was right ventricle–dependent in one. Furthermore, those
patients with any evidence of flow through the pulmonary
valve, according to either color Doppler echocardiography
or angiography, were excluded from the study and treated
by conventional balloon dilation. In all 12 patients, the
arterial duct was maintained open before the procedure
with an infusion of prostaglandin E2. The median age at
the time of the procedure was 9 days (range 1 to 74 days),
the median weight 3.06 kg (range 0.8 kg to 4.15 kg), and
the median body surface area (BSA) 0.21 m2 (range 0.11
m2 to 0.25 m2). In three of the patients the diagnosis of
pulmonary valve atresia had been made prenatally.
Procedure. Cardiac catheterization was performed with
general anesthesia in all the patients. The femoral artery
and vein were cannulated percutaneously in all except one
patient who required a cutdown onto the left femoral vein
and cannulation of the umbilical artery (preterm baby
weighing 800 gm). Heparin (30 U/kg) was administered
once the vascular access was obtained. Usually a 4F sheath
was inserted in the femoral artery and a 5F sheath in the
femoral vein. The technique of pulmonary valvotomy has
been described in detail previously.18, 19 In the first six
patients, laser-assisted valvotomy was performed with an
0.018-inch laser guide wire.18 In the last five patients,
radiofrequency-assisted valvotomy was performed with
the use of an 0.020-inch or an 0.018-inch radiofrequency
guide wire.19 In one patient, both laser and radiofre-
quency wires were used. Once the wire had perforated the
atretic valve, subsequent balloon dilation of the valve was
performed with balloons of progressively increasing size
up to the valve anulus diameter. In four patients the
arterial duct was also dilated with a balloon during the
same procedure to improve the oxygen saturations, and in
one patient the dysplastic, poorly mobile tricuspid valve
on echocardiography was also dilated during the same
procedure.
Postcatheter management. After completion of the
procedure, the patients were kept in the intensive care
unit and progressively weaned from ventilation and pros-
taglandin infusion when the oxygen saturations were
satisfactory. In the patients who remained severely hy-
poxic immediately after the procedure despite prostaglan-
din infusion (oxygen saturations below 65% or desatura-
tions with acidosis) or in the patients who remained
prostaglandin-dependent up to 1 month after the proce-
dure, further interventions were considered, such as bal-
loon dilation of the arterial duct, stenting of the arterial
duct, repeat balloon dilation of the right ventricular
outflow tract, or insertion of a modified Blalock-Taussig
shunt. These patients are referred to in the text as
“remaining prostaglandin-dependent.” In patients in
whom the catheter valvotomy procedure had failed, sur-
gical pulmonary valvotomy or modified Blalock-Taussig
shunt insertion was considered.
Follow-up. After discharge from the hospital, the pa-
tients were reviewed regularly, usually with an assessment
of oxygen saturation and cross-sectional echocardiogra-
phy. Further cardiac catheterizations with or without
intervention and surgical interventions were performed
when clinically indicated.
Assessment of right ventricular size and growth. All
the cross-sectional echocardiograms were retrospectively
reviewed by one person (C.O.). The largest diameter of
the tricuspid valve and the mitral valve anulus were
measured in diastole from the apical four-chamber view.
The tricuspid valve dimensions were expressed as Z-
values using the nomograms based on the published
echocardiographic data.20, 21 The transformation of a
dimension into a Z-value is based on the following
equation21:
Z-value 5
Observed dimension – Mean normal dimension
Standard deviation around mean normal dimension
The ratio of the tricuspid valve to BSA was used as an
alternative for relating the tricuspid valve dimensions to
growth. The ratio of the tricuspid valve to the mitral valve
was also calculated.
Data analysis. The 12 patients were divided into three
groups according to their outcome. Group 1 consisted of
patients who survived after successful transcatheter valvo-
tomy (n 5 6); group 2 comprised patients who died after
successful transcatheter valvotomy (n 5 3); and group 3
was composed of patients who died after unsuccessful
transcatheter valvotomy (n 5 3). The results are expressed
as medians with ranges. To compare initial data with
follow-up data, we used a paired Student’s t test.
Results
Short-term results. Successful perforation of the
pulmonary valve and subsequent balloon dilation
was achieved in nine (75%) of the 12 patients (Fig.
1). In three (25%) of the 12 patients, catheter
valvotomy was unsuccessful. In the first patient, the
laser wire passed from the infundibulum into the
pericardium causing cardiac tamponade, which re-
sponded to needle aspiration. The child underwent
an urgent operation but died in the operating room
of coronary artery air embolism. Coexistent infun-
dibular atresia was noted. The second patient was a
preterm baby weighing 800 gm, in whom venous and
arterial access required the use of the umbilical
artery and cutdown of the femoral vein. The pulmo-
nary artery was perforated during the procedure and
the child died of cardiac tamponade in the catheter-
ization laboratory. Autopsy also showed coexisting
infundibular atresia. In the last patient, both laser
and radiofrequency wires were positioned in the
outflow tract sequentially, but a stable position
could not be obtained. The procedure was therefore
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abandoned and the patient referred for surgical
valvotomy 2 days later. After the valvotomy, the
child remained deeply cyanotic. Surgical closure of
the atrial septal defect was performed 24 hours later
but the child died soon after returning to the
intensive care unit.
Complications. In four of the nine patients in
whom the pulmonary valve was successfully dilated,
the main pulmonary artery was perforated by the
laser or radiofrequency guide wire, resulting in
cardiac tamponade in three and no hemodynamic
effects in one. Surgical repair of the pulmonary
artery perforation was required in only one of these
patients; in the other two, cardiac tamponade was
relieved by percutaneous pericardiocentesis before
completion of the procedure. The patient in whom
the pulmonary artery was perforated without car-
diac tamponade also had a dissection of the femoral
artery caused by the catheter, resulting in femoral
artery occlusion. Heparin was not used after the
procedure because of the pulmonary artery perfora-
tion, and the foot pulses returned to normal over the
next 3 days.
Early outcome. Fig. 1 summarizes the outcome
of the 12 patients after cardiac catheterization. Of
the nine patients in whom the pulmonary valve
had been successfully opened, two were success-
fully weaned from prostaglandin infusion 7 and 19
days after the valvotomy. These patients had the
highest initial tricuspid Z-values (Z-value 5 – 0.4
for both). The other seven patients remained
prostaglandin-dependent up to 1 month after the
procedure. In three of these, additional transcath-
eter procedures were performed on the arterial
duct. These included dilation of the arterial duct
with a balloon 4 and 7 days after the catheter
valvotomy in one patient and, in the second, 2
days after the valvotomy. In both of these pa-
tients, the arterial oxygen saturation improved
and the prostaglandin infusion could be stopped.
However, in the second patient, because of recur-
rent hypoxia, the duct was redilated 35 days after
the catheter valvotomy when it was combined with
balloon dilation of the right ventricular outflow
tract and the tricuspid valve. In the third patient,
a stent was implanted in the arterial duct in
addition to repeat balloon dilation of the pulmo-
nary valve 36 days after the initial catheter valvo-
tomy, after which the prostaglandin infusion was
stopped. A further two patients had modified
Blalock-Taussig shunts inserted 5 and 9 days,
respectively, after the valvotomy. One of these
two continued to have persistent low arterial
oxygen saturation despite the shunt and died of
multiorgan failure and sepsis 18 days after the
catheter valvotomy. In the other patient, the shunt
operation was performed before the patient re-
turned abroad. The two remaining patients, who
were prostaglandin-dependent, had severe sepsis
and multiorgan failure and died 6 and 33 days
after the catheter valvotomy. The cross-sectional
echocardiograms performed before death showed
Fig. 1. Early results in the 12 neonates and infants with pulmonary atresia and intact ventricular septum
in whom transcatheter pulmonary valvotomy was attempted as the initial treatment. RF, Radiofrequency;
PGE2, prostaglandin E2, PDA, patent arterial duct; BT shunt, modified Blalock-Taussig shunt.
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unobstructed antegrade flow across the pulmo-
nary valve, significant pulmonary and tricuspid
regurgitation, and a right-to-left shunt at the atrial
level.
Late outcome. Of the six surviving patients, one
is being followed up abroad and is clinically well 8
months after catheter valvotomy and modified
Blalock-Taussig shunt insertion, but no detailed
echocardiographic data are available. The median
follow-up for the other five is 60 months (range 37
to 68 months). Since discharge from the hospital,
two of the five patients have required no further
transcatheter or surgical intervention. In one of
these two patients, a stent had been inserted in
the arterial duct 36 days after the catheter valvot-
omy and before discharge. The stent was found to
be occluded 2 years after insertion without any
clinical deterioration or fall in oxygen saturation.
Three other patients have required further bal-
loon dilation of the right ventricular outflow tract
3 to 45 months after the valvotomy; in one of them
no other treatment was needed. In one, this was
followed by surgical right ventricular outflow tract
reconstruction with atrial septal defect closure 67
months after the initial catheter valvotomy, and
one patient had surgical closure of an atrial septal
defect 41 months after the catheter valvotomy.
Thus two of the patients have required surgical
closure of the atrial septal defect. At the latest
follow-up, the systemic arterial oxygen saturation
for the five patients ranged between 94% and
98%, suggesting no significant right-to-left shunt-
ing. The Doppler gradients across the pulmonary
valve ranged between 4 and 25 mm Hg. Mild
pulmonary regurgitation was present in four and
no pulmonary regurgitation in one. All of the five
patients thus have two-ventricle circulation with
the help of surgery in two and without any surgery
in three.
Growth of the right ventricle
Initial tricuspid valve anulus measurements. Table
I shows the clinical and echocardiographic data for
the three groups of patients at the time of the initial
cardiac catheterization. The tricuspid valve of one of
the patients in group 3 was 3.5 mm and could not be
expressed as a Z-value because no normal echocar-
diographic data exist for his BSA (0.11 m2).
Growth of the tricuspid valve anulus. Five of the six
survivors have been followed up by serial cross-sec-
tional echocardiography. In Fig. 2, the serial dimen-
sions of the tricuspid valve, expressed in millimeters
(Fig. 2, a), the tricuspid valve Z-values (Fig. 2, b), and
the tricuspid/mitral valve ratios (Fig. 2, c) are related
to BSA. In all patients, the absolute dimensions of the
tricuspid valve increased with growth. However, in
three of the patients, the absolute dimensions of the
tricuspid valve diverged below 2 standard deviations
from the mean derived from the normal data pub-
lished by King and associates20 (Fig. 2, a). This was
further confirmed by the Z-values of the tricuspid
valve growth, and therefore the right ventricular
growth lagged behind the normal body growth. The
ratio of the tricuspid valve to mitral valve dimensions
showed a linear increase in four of the five patients,
but in only one patient has the ratio reached 1.0 (Fig.
2, c). Table II compares the initial data, expressed as
medians with ranges, in these five patients with those
at the latest follow-up. There is a significant change in
the tricuspid valve anulus, its Z-values, and the ratio of
tricuspid valve to mitral valve.
All five patients have two-ventricle circulation,
with or without additional surgery, despite smaller
than normal tricuspid valve dimensions or Z-values.
Discussion
Initial treatment strategy. The management of
neonates with pulmonary valve atresia and intact
ventricular septum remains difficult because of the
Table I. Comparison of the clinical and echocardiographic data at the time of catheter pulmonary valvotomy
among the three groups
Group 1 (n 5 6) Group 2 (n 5 3) Group 3 (n 5 3)
Age (days) 7.5 (1 to 51) 5 (3 to 10) 14 (11 to 75)
Weight (kg) 2.9 (2.1 to 3.9) 3.2 (2.7 to 3.45) 3.2 (0.8 to 4.15)
BSA (m2) 0.195 (0.18 to 0.24) 0.21 (0.19 to 0.22) 0.22 (0.11 to 0.25)
TV anulus (mm) 10 (8 to 12) 8 (8 to 10) 7 (3.5 to 12.5)
TV/BSA ratio 48 (41 to 57) 41 (37 to 44) 32 (31 to 50)
TV Z-value 20.8 (21.3 to 20.4) 21.2 (21.5 to 20.7) 22.1 and 20.7*
TV/MV ratio 0.615 (0.56 to 0.8) 0.67 (0.57 to 0.67) 0.5 (0.35 to 0.83)
Results are expressed as medians for the groups with ranges in parentheses. BSA, Body surface area; TV, tricuspid valve; MV, mitral valve.
*Z-values are given for the two patients in group 3 for whom such values could be calculated.
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wide variations of the anatomy, such as the size and
the morphology of the right ventricle and possible
associated abnormalities of the coronary artery cir-
culation. Treatment strategies have been influenced
by these anatomic variations.3-6, 8, 9, 11-13, 15, 17 In
those patients with a severely hypoplastic bipartite
right ventricle or a right ventricle–dependent coro-
nary artery circulation, a systemic–pulmonary artery
shunt is usually the initial treatment. In such cases,
a two-ventricle circulation in the future is unlikely
and a palliative approach such as the Fontan oper-
ation is preferred. When the coronary artery circu-
lation is not dependent on the high-pressure right
ventricle or when the right ventricle is of a “reason-
able” size and has an infundibulum, early opening of
the right ventricular outflow tract has been advo-
cated to try to stimulate growth of the right ventri-
cle. In such cases, the usual approach is a surgical
valvotomy or right ventricular outflow tract patch
with or without an additional systemic–pulmonary
artery shunt. The importance of obtaining adequate
relief of the right ventricular outflow tract obstruc-
tion with low right ventricular pressures has been
stressed to promote as much as possible regression
of right ventricular hypertrophy and growth of the
right ventricular cavity.4, 17 A prospective, multi-
center study between 1987 and 1991 reported by
Hanley and associates5 showed survival after surgi-
cal valvotomy, with or without a shunt, to be influ-
enced by the initial tricuspid valve Z-value. For
patients with an initial tricuspid valve Z-value of –2
or higher (similar to our population), survival at 6
months was at least 86% with shunts and 77%
without shunts.
In 1991, transcatheter pulmonary valvotomy was
first described by Qureshi and colleagues18 as an
alternative to surgical valvotomy to establish ante-
grade flow in pulmonary valve atresia. Since then,
the technical skills for this demanding procedure
have improved, the indications have become more
precise, and more centers have begun to use this
approach.19, 22-26 The current report includes the
entire learning curve with regard to the selection of
patients and the technique. This explains the high
overall mortality and morbidity when compared
with the current surgical results.5 Two of the pa-
tients in our series in whom the procedure failed
were considered in retrospect to be unsuitable can-
didates for catheter valvotomy because of the pres-
ence of infundibular atresia. In addition, most pro-
cedural complications were encountered in our early
experience. From the experience of other centers
performing catheter valvotomy by these methods, it
seems clear that the procedure can be considered as
an alternative to surgical valvotomy, when the pa-
tients are carefully selected.24-28 Only those patients
Fig. 2. Growth of the tricuspid valve as measured on
serial cross-sectional echocardiograms in five of six survi-
vors. a, Tricuspid valve (TV) dimensions, expressed in
millimeters. Normal dimensions with mean and standard
deviations, adapted from King’s normal echocardio-
graphic data,20 are shown. b, Tricuspid valve Z-values. c,
Tricuspid valve/mitral valve ratio (TV/MV).
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with membranous valvular atresia and a patent
infundibulum, in the setting of a non-right ventricle–
dependent coronary circulation, should be consid-
ered for this procedure.
In addition to opening the right ventricular out-
flow tract, the need for a systemic–pulmonary shunt
is an important question. The length of time that the
pulmonary blood flow needs to be augmented by a
shunt is not clear, because it is difficult, if not
impossible, to judge when the right ventricle has
become capable of supporting the pulmonary circu-
lation on its own without the help of such a shunt.
Kirklin and Barratt-Boyes1 estimated the freedom
from systemic–pulmonary artery shunt 1 month
after surgical valvotomy or pulmonary atresia to be
48% when the Z-value of the tricuspid valve was –1
and 34% when the Z-value was –2. In our study, 1
month after catheter valvotomy, 33% (2/6) of the
surviving patients were not duct-dependent. In our
institution, we have attempted to avoid surgical
shunts, when possible, to avoid distortion of the
pulmonary arteries. Thus, of the four duct-depen-
dent patients, only one had a surgical Blalock-
Taussig shunt, whereas the others had catheter
approaches to maintain the arterial duct open. The
advantage of such an approach is that the duct can
close spontaneously over weeks or months after
balloon dilation or even stent implantation, but by
then, it appears as though the right ventricle has
become capable of being the sole supply of pulmo-
nary blood flow. Other centers performing this
procedure may have lower thresholds and different
indications for proceeding to a surgical or transcath-
eter shunt.26
Assessment of right ventricular size. Inasmuch as
the right ventricular volume is difficult to assess,
tricuspid valve dimensions are generally used in the
determination of treatment strategies.1, 5 Different
studies have reported that a good correlation exists
between the dimension of the tricuspid valve and the
size of the right ventricle in pulmonary atresia and
intact ventricular septum.1, 5, 11 Z-values have been
widely used to standardize dimensions and require
reliable and representative normal values.21 Autop-
sy,29 echocardiographic,20 and angiographic30 data
on tricuspid valves in normal children are available
but differ substantially from each other. Several
authors have used Z-values of tricuspid valves de-
rived by echocardiography or angiography, but
based on Rowlatt’s autopsy data for their stud-
ies.4, 5, 21, 29 It is difficult to compare measurements
taken by different methods, and there is no clear
correlation between autopsy and echocardiographic
measurements with growth. Serial echocardio-
graphic measurements are hard to interpret if they
are expressed as Z-values based on autopsy data.
Because of our serial echocardiographic measure-
ments, we have opted to use echocardiographic
measurements published by King and associates in
calculating the Z-values.20
Growth of the right ventricle. The potential for
growth of the right ventricle after valvotomy re-
mains largely unknown and seems difficult to pre-
dict. Even severely hypoplastic ventricles may
grow.13, 15 In addition, it is impossible to judge the
size of the right ventricle that will contribute to a
successful two-ventricle circulation. Questions arise
as to whether the initial size of the right ventricle is
really important in the initial treatment strategy and
whether the right ventricle needs to be of normal
size to support the pulmonary circulation on its own.
The minimal tricuspid valve Z-value before catheter
valvotomy in our study was –2.1 except in the
preterm baby (800 gm), for whom echocardio-
graphic normal Z-values are not available. Thus the
right ventricle was of a “reasonable” size in all the
patients. The tricuspid valve measurements, Z-val-
ues, and the ratio of the tricuspid valve to BSA
tended to be smaller in groups 2 and 3 than in group
1, suggesting that these children had more severe
hypoplasia of the right ventricle. This supports the
suggestion that the initial Z-value of the tricuspid
valve, and thus the size of the right ventricle, is likely
to be a determinant of survival after valvotomy.5 In
five of the six survivors, although the absolute
tricuspid valve dimensions increased during follow-
up, there was a trend toward deviation away from
the normal range in three of the patients. The
Z-values of the tricuspid valve also decreased in
most of the patients. Despite the subnormal size of
the right ventricle, five of six children have two-
ventricle circulation. Therefore it appears as though
Table II. Comparison of initial echocardiographic
data with data at latest follow-up examination in five
of the six survivors
Initial data Latest follow-up
p
Values
TV anulus
(mm)
10 (8 to 12) 21 (19 to 24) 0.00019
TV Z-score 20.7 (21 to 20.4) 22.3 (21.1 to 22.9) 0.0097
TV/MV ratio 0.6 (0.56 to 0.8) 0.88 (0.76 to 1) 0.01
Values are expressed as medians with ranges in parentheses. TV, Tricuspid
valve; MV, mitral valve.
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normal tricuspid valve growth is not mandatory to
have a right ventricle capable of sustaining the
pulmonary circulation. Hanley and associates5 ana-
lyzed combined data from several studies on right
ventricular growth after surgical treatment.6, 12, 13
This multivariate analysis indicated that the Z-value
of the tricuspid valve did not change during the
follow-up period in patients in whom right ventricu-
lar–pulmonary artery continuity was established as
the initial procedure. However, it is difficult to
compare our data with the data of Hanley and
coworkers, because their Z-values were derived
from autopsy measurements.
Limitations of our study. The small number of
patients and the retrospective nature of the study
are major limitations. No surgical control group is
available with which to compare the results of the
transcatheter approach. In addition, the patients do
not cover the whole spectrum of pulmonary atresia
and intact ventricular septum, and only the favor-
able end of the spectrum is seen with patients with
initially reasonably good-sized right ventricles. No
data are thus available on the potential for growth of
“very small” right ventricles.
Conclusion
Transcatheter pulmonary valvotomy is an alterna-
tive treatment for neonates and infants with pulmo-
nary valve atresia and intact ventricular septum,
although proper selection of patients is required.
The technique allows growth of the right ventricle
and makes it possible for the patients to have
two-ventricle circulation, even when right ventricu-
lar growth is suboptimal.
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